CN115737520A - 一种控油祛痘清颜组合物 - Google Patents
一种控油祛痘清颜组合物 Download PDFInfo
- Publication number
- CN115737520A CN115737520A CN202211627852.4A CN202211627852A CN115737520A CN 115737520 A CN115737520 A CN 115737520A CN 202211627852 A CN202211627852 A CN 202211627852A CN 115737520 A CN115737520 A CN 115737520A
- Authority
- CN
- China
- Prior art keywords
- acne
- oil
- face
- skin
- hexapeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 64
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000004140 cleaning Methods 0.000 title abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 208000020154 Acnes Diseases 0.000 claims abstract description 14
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 13
- GFEYWOGCSROPRT-OBXVVNIGSA-N (2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 GFEYWOGCSROPRT-OBXVVNIGSA-N 0.000 claims abstract description 10
- SAVSLMGBKQKUAV-JYJNAYRXSA-N (2s)-2-[[(2s)-3-(4-hydroxyphenyl)-2-[[(2s)-3-methyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]amino]propanoyl]amino]-3-methylbutanoic acid Chemical compound FC(F)(F)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 SAVSLMGBKQKUAV-JYJNAYRXSA-N 0.000 claims abstract description 10
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 10
- 108010047657 Phe-Val-Ala-Pro-Phe-Pro Proteins 0.000 claims abstract description 10
- PEUSZTDUWXURQK-BZRHSMGTSA-N methyl (2s)-2-[[(2s)-2-[[(3s,4s)-4-[[(2s)-2-[[2-[[(2s)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]propanoyl]amino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CC=CC=C1 PEUSZTDUWXURQK-BZRHSMGTSA-N 0.000 claims abstract description 9
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 9
- 108010030856 phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester Proteins 0.000 claims abstract description 9
- 125000001453 quaternary ammonium group Chemical class 0.000 claims abstract description 9
- 244000186892 Aloe vera Species 0.000 claims abstract 4
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 8
- 229940055019 propionibacterium acne Drugs 0.000 abstract description 8
- 230000028327 secretion Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 229920000832 Cutin Polymers 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000001276 controlling effect Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000001902 propagating effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000002374 sebum Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 238000011282 treatment Methods 0.000 description 22
- 210000003491 skin Anatomy 0.000 description 20
- 239000003814 drug Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 230000006872 improvement Effects 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 206010033733 Papule Diseases 0.000 description 8
- 206010037888 Rash pustular Diseases 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 208000029561 pustule Diseases 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 244000144927 Aloe barbadensis Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 241001116389 Aloe Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 3
- 206010039580 Scar Diseases 0.000 description 3
- 240000004534 Scutellaria baicalensis Species 0.000 description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 3
- 206010039792 Seborrhoea Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 208000008742 seborrheic dermatitis Diseases 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000037740 Coptis chinensis Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000003851 biochemical process Effects 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 206010000503 Acne cystic Diseases 0.000 description 1
- 208000020576 Adrenal disease Diseases 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 244000097577 Rhus javanica Species 0.000 description 1
- 235000010889 Rhus javanica Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- -1 benzene peroxide Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000005739 manihot Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 1
- 229960003053 thiamphenicol Drugs 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种控油祛痘清颜组合物,属于化妆品领域。本发明提供的控油祛痘清颜组合物包括如下重量百分比的组分:50‑70%库拉索芦荟叶水、0.0005‑0.05%季铵盐‑73、0.0005‑0.05%六肽‑5、0.0002‑0.02%棕榈酰三肽‑8、0.0002‑0.02%六肽‑11、0.00002‑0.002%三氟乙酰三肽‑2。本发明控油祛痘清颜组合物将从调节皮脂分泌、去角质、抑制痤疮丙酸杆菌繁殖、抗炎这四个维度着手来预防以及清除痤疮,不仅高效,而且非常温和,还可以加速皮肤的代谢循环、洁净清颜。本发明的控油祛痘清颜组合物成分清晰,安全性好。
Description
技术领域
本发明属于化妆品制备技术领域,具体的说,涉及一种控油祛痘清颜组合物。
背景技术
痤疮(粉刺、青春痘)是由内分泌失调引起的局部皮肤皮脂腺失控,皮肤分泌代谢功能障碍而引发的一种常见皮肤病。内分泌失调的原因很多,治疗痤疮的药物及美容护肤品也很多,但是大多数治疗不彻底,治疗后面部仍然留有疤痕,影响美观。
西医认为,生长青春痘的原因是由于体内雄性激素分泌增多或相对增高,从而刺激皮脂腺增生肥大,分泌油脂量上升,使毛囊阻塞,引起病原菌感染,导致非特异性炎症反应。西医治疗青春痘的药物主要有:(1)四环素、美满霉素、红霉素、氯洁霉素等抗生素;(2)安体舒通、酮糠唑、西米替丁、复方炔诺酮、甲氰咪呱等激素类药;(3)硫磺、维A酸类、过氧化苯等其它化合物。但采用西医治疗法容易引起肾上腺皮质功能紊乱、皮肤老化、菌群交替症、轻度恶心、慢性中毒等副作用。
青春痘是一种多因素的疾病,其发病主要与性激素水平、皮脂腺大量分泌、痤疮丙酸杆菌增殖,毛囊皮脂腺导管的角化异常及炎症等因素相关。因此,一个祛痘配方的设计应该考虑到以下几因素:(1)选择高效安全抗菌消炎活性成分,能够迅速杀灭痤疮丙酸杆菌、螨虫等皮肤寄生菌群,防止细菌原体浸蚀而发炎长痘,同时能起到消炎的作用。(2)加入适当的角质处理剂和控油成分,抑制油脂分泌,疏通毛囊,全面加速角质细胞代谢、剥落表皮死亡组织。(3)含有保湿活性成分,防止皮肤变得干燥,使皮肤保持正常的润湿状态,促进活性物的释放与透皮吸收,确保活性成分快速到达病灶部位。
从中医学的角度来看,导致痤疮的原因主要有肺热血热、肠胃湿热、脾虚痰湿、瘀血阻滞,肾阴不足、情志不节、外感风热、气血凝滞和血郁痰结等方面。目前祛痘的中药多为消热化湿(如黄芩、黄连等)、泻炎解毒(如石膏、栀子等)、凉血活血(如生地、丹参、丹皮等)、解毒消痈化脓(如野菊花、蒲公英等)。
申请号为CN200310106513中国发明专利公开了一种治疗座疮的复方制剂,由甲砜霉素、氯喹、吲哚美辛为主料复配而成。该药物若长期使用,将对人体的皮肤、肝和肾脏有一定的毒性作用。申请号为CN200710014138中国发明专利申请公开了治疗痤疮的药物,由批把叶、知母、桅子、菊花、蒲公英、玄参、黄柏、皂角刺、紫草、丹参和甘草按一定重量配比制作而成。申请号为CN200710035784的中国发明专利公开了祛痘面霜,组方中至少包括土茯苓、薏苡仁、葛根、黄芪、菊花、麦冬、灵芝和虎杖组分中的5种。申请号为CN200710078403中国发明专利申请公开了一种具有祛痘、添坑、消斑的中药组合物,按重量比组成:石菖蒲10份,五味子8份,鸭胆子1份,五加皮3份,大黄2.5份。申请号为CN200810145228中国发明专利申请公开了一种治疗痤疮的药物,将含有一定配比的苦参、桅子、黄连、黄芩、蒲公英、大青叶、天花、蛇床子、茵陈、大黄、黄柏、丹参、连翘中药材,经粉碎后,分别用乙醇回流提取和水煮提取、过滤浓缩至干,最后将醇干膏粉和水干膏粉充分混合制得各味原料药的最终干粉。申请号为CN200910235809中国发明专利公开了一种复方祛痘中药提取物及其制备方法,由丹参、丁香、黄芩、大黄和厚朴中药组成,按一定的配比用无水乙醇提取后,过滤、浓缩、灭菌得到成品。申请号为CN201210439331中国发明专利公开了一种具有祛痘功效的药物组合物及其制备方法,由丹参25-35份、旱莲15-25份、白芷10-20份、干姜10-20份、黄芩5-15份、芦荟5-15份药材组成,醇提取后、过滤、浓缩至干得成品。以上公开的祛痘组合物制备方法相对粗放,多为加热提取,未有分离纯化,存在产品成分不清楚,杂质多,稳定性差,安全性差,容易引起刺激反应等缺点。
发明内容
本发明的目的是针对现有技术存在的不足,提供一种无刺激、无激素、无抗生素、不易反弹、疗效确切的具有控油、祛痘和清颜的组合物。能用于预防和治疗青春痘,其效果明显,作用快,去除痘疤,消除病灶表面凹凸不平,并兼有洁净和清颜功效。
为实现上述目的,本发明是通过如下技术方案实现的:
所述的控油祛痘清颜组合物,包括如下组分:库拉索芦荟叶水、季铵盐-73、六肽-5、棕榈酰三肽-8、六肽-11、三氟乙酰三肽-2。
所述的控油祛痘清颜组合物,按重量百分含量计,包含以下重量百分含量的组分:30-90%库拉索芦荟叶水、0.0005-0.05%季铵盐-73、0.0005-0.05%六肽-5、0.0002-0.02%棕榈酰三肽-8、0.0002-0.02%六肽-11、0.00002-0.002%三氟乙酰三肽-2。
优选地,所述的控油祛痘清颜组合物,按重量百分含量计,包含以下重量百分含量的组分:40-80%库拉索芦荟叶水、0.001-0.008%季铵盐-73、0.002-0.008%六肽-5、0.001-0.003%棕榈酰三肽-8、0.001-0.003%六肽-11、0.0001-0.0003%三氟乙酰三肽-2。
更优选地,所述的控油祛痘清颜组合物,按重量百分含量计,包含以下重量百分含量的组分:50-70%库拉索芦荟叶水、0.003-0.007%季铵盐-73、0.003-0.007%六肽-5、0.0015-0.0025%棕榈酰三肽-8、0.0014-0.0026%六肽-11、0.00017-0.00023%三氟乙酰三肽-2。
所述的控油祛痘清颜组合物作为护肤品添加剂的应用。
本发明的有效成分的作用机理或特点:
库拉索芦荟叶水含有多重天然护肤成分,如糖类、氨基酸和各种有机酸、矿物质、维生素等,具有易渗透吸收的特点;此外,还具有促进伤口愈合、增强组织生化过程、刺激细胞内部反应,促进细胞生长和分裂,加快受伤组织康复和愈合的作用。
库拉索芦荟叶水的制备方法:将库拉索芦荟叶用去离子水清洗干净除去杂质,并在40-60℃下进行干燥,将干燥后的库拉索芦荟叶切碎后,再与去离子水按照质量比为1:10进行混合,在超声频率为50KHz、温度为50℃、1.3个大气压条件下,超声提取3小时,冷却至室温,过滤除去杂质,即得到库拉索芦荟叶水。
季铵盐-73:具有极强的抗菌活性,可破坏细菌真菌细胞膜,对丙酸痤疮杆菌有极好的效果,可以强效抑制黑色素形成。
六肽-5:是一种皮肤调理剂,可有效促进胶原蛋白,弹力纤维和透明质酸再生,提高肌肤的含水量,加强肌肤厚度,减少表情纹皱纹,改善肌肤健康状态。
棕榈酰三肽-8:是一种皮肤调理剂,具有强大的抗氧化、抗老化的功效,可以最大程度促进细胞的再生和分化,消灭皱纹、细纹、暗纹。
六肽-11:六肽-11可促进皮肤细胞外基质的相关基因表达,促进成纤维细胞合成胶原蛋白、弹性蛋白,提高皮肤弹性与紧致度,改善静态皱纹。
三氟乙酰三肽-2:三氟乙酰基三肽-2可以很好地增加皮肤弹性、紧致度并减少皮肤松弛。
本发明的有益效果:
本发明提供的控油祛痘清颜组合物,通过多种营养成分的合理配制。从促进伤口愈合、增强组织生化过程、刺激细胞内部反应、促进细胞生长和分裂、加快受伤组织康复和愈合、抑制油脂分泌、抑制痘痘生成、抑制丙酸痤疮杆菌、抑制黑色素生成、促进肌肤胶原蛋白再生、增加肌肤含水量等多个方面起到全面治疗青春痘和清颜的效果。成分明确,各组份互相协同,无毒副作用,疗效显者。
附图说明
图1控油祛痘清颜效果图。
具体实施方式
为了使本发明的目的、技术方案和有益效果更加清楚,下面将对本发明的优选实施例进行详细的说明,以方便技术人员理解。
实施例1:抗菌测试
根据本领域技术人员所熟知的常规方法制成如表1所示的控油祛痘清颜组合物。
表1控油祛痘清颜组合物
为验证本发明所述组合物在抗菌方面的效果,参照GB15979-2002《一次性使用卫生用品卫生标准》附录C4“溶出性抗(抑)菌产品抑菌性能试验方法”对本发明的组合物进行抑菌性能测定:
1)测试样品:采用实施例1表1中的样品。
2)菌悬液的制备:取痤疮丙酸杆菌24h培养物用0.03mol/L磷酸盐缓冲液洗下,制成104~106CFU/mL菌悬液。
3)分别取测试样品1g,加入上述菌悬液0.1mL均匀涂布混合,开始计时,20min后加入9mL0.03mol/L磷酸盐缓冲液充分混匀,做适当稀释后,取其中3个稀释度,分别取1mL置于两个平行平皿中,再加入相应培养基在36±1℃厌氧条件下培养24h,作菌落计数。以上试验重复3次,取平均数,设置空白对照组。
抑菌率的计算公式为:X=(M-N)/M×100%,其中X为抑菌率,M为对照样品平均回收菌落,N为试验样品平均回收菌落。
功效评价标准为:(1)抑菌率≥90%为显效;(2)抑菌率50~90%为有效;(3)抑菌率<50%为无效。
表1中A、B、C、D、E、F的组合物制得的乳液的抗菌功效测试结果见表2。
表2抗菌测试结果
从表2可以看出,A、B、C的乳液对痤疮丙酸杆菌的抑菌效果明显,说明本发明的组合物科学配比,能显著抑制痤疮丙酸杆菌的增殖,可有效预防或改善皮肤的痤疮症状。
实施例2:祛痘效果测试
将实施例1中表1的控油祛痘清颜组合物A按照如下方法制备成控油祛痘清颜面膜:将实施例1表1中具有控油祛痘清颜组合物A、羧甲基纤维素加入到去离子水中,搅拌均匀后加入维生素E、植物油、氢化可可脂及乳化剂均质乳化,然后加入山梨醇和甘油以及用于辅助的防腐剂及香精等,搅拌均匀即可。其中,所述植物油可以选用大豆油,乳化剂可以是吐温20或者吐温80。
祛痘效果测试实验设计如下:随机选取15-35岁的青春痘患者100例,其平均年龄为22岁,其中男性60例,女40例。每日早晚各一次,敷于患处,共治疗一个月。
1、疾病分级:
(1)轻度(I级):表现为粉刺为主,少量丘疹和脓疱,总病灶数少于30个;
(2)中度(II级):表现为有粉刺,中等量的丘疹和脓疱,总病灶数31-50之间;
(3)中度(III级):表现为大量丘疹和脓疱,偶见大的炎性皮损,分布广泛,总病灶数在51-100之间,结节小于3个;
(4)重度(IV级):表现为结节/囊肿性痤疮或聚合性痤疮,多数有疼痛并形成囊肿和窦道,总病灶数100个以上,结节/囊肿在3个以上。
2、疗效评定标准与治疗结果:
痊愈:痘疤痘印消失,皮肤平滑光洁,停药3个月无复发;
有效:总皮损数明显减少;
无效:临床症状无明显变化,总皮损数无减少。
3、治疗效果
表3祛痘效果测试结果
结果表明本发明的控油祛痘清颜组合物A在祛痘效果上具有明显的效果,总有效率达到97%。
实施例3:控油祛痘清颜效果测试
将实施例1中表1的控油祛痘清颜组合物A按照如下方法制备成控油祛痘清颜凝露:将实施例1表1中具有控油祛痘清颜组合物A加入到去离子水中,搅拌均匀后加入甘油、植物油、1,3-丙二醇、支链淀粉、葡聚糖、黄原胶及乳化剂搅拌均匀,均质乳化即可。其中,所述植物油可以选用氢化蓖麻油,乳化剂可以是PEG-40、吐温20或者吐温80。
控油祛痘清颜效果测试实验设计如下:
测试者资料:共入组20例痤疮测试者,男性6例,女性14例;年龄16-25岁,平均22.1岁。
发病影响因素:饮食:辛辣8例、甜食7例、高脂肪5例、无关6例;与便秘有关者8例;与气候有关者5例;与精神压力有关者12例;女性测试者中与月经相关者10例。
入选标准:参考PillSburv及国际改良痤疮分级法诊断轻中度痤疮患者;男女不限;愿意在试验期间遵守合并用药限制的规定。
测试方法和疗程:(1)使用方法:测试者清洁面部后于皮损处外涂一薄层控油祛痘清颜凝露,每日早晚各1次。不要在沐浴、剃须、桑拿浴或剧烈运动(如引起出汗)之前2小时和之后30分钟之内使用。(2)疗程:本试验共2周,分三次观察评分,分别为治疗第1日、治疗1周后及治疗结束日,如果治疗一周时症状已经“消除”,则外用仍继续使用至总共2周后才能停止。
疗效标准:(1)对各项体征和瘙痒症状的评分:在治疗第1日、治疗1周后及治疗结束时给以下四项体征评分:粉刺、丘疹、脓疱、脂溢程度。各项体征为0-3四级评分。计算改善度,公式:[治疗前评分(四项体征评分之和)-治疗后评分(同前)]/治疗前评分×100%。(2)对临床反应评价:治疗1周后及治疗2周后分别对治疗第1日以来的临床状况改变做一评估。
临床痊愈:皮损基本消失,积分减少≥95%;
显效:残留少量粉刺、丘疹,积分减少≥70%;
有效:皮损好转,积分减少≥30%
无效:无改善,甚加重,积分减少<30%
结果:疗效总评:痊愈率为15%、显效率为30%,有效率为45%、总有效率为90%,无效率为10%(见表4)。起效时间为2天至1周不等,平均起效时间3天。
表4疗效总评表
临床症候中粉刺改善率为41.7%,丘疹、脓疱改善率58.6%,脂溢程度改善率为31.7%(见表5)。上述数据表明净痘系列产品治疗轻中度痤疮有一定疗效。
表5临床症候改善情况
效果分析:根据自述效果及测试评分评价,本产品对轻中度痤疮有一定效果,总有效率90%。从症候改善情况分析:对面部粉刺及丘疹、脓疱的改善较为明显,改善率分别为44.7%和60.2%,其中对丘疹、脓疱的改善尤为显著,无论是从测试评价还是从测试者自我反馈来看,该药物对炎症较明显的皮损效果较好;此外,该药物对面部脂溢程度也有一定程度的改善,改善率为42.8%。
安全性分析:在治疗观察期间,所有测试者均未出现任何不良事件,由此可知,本产品治疗轻中度痤疮的安全性较好。
部分测试者治疗效果:本发明的控油祛痘清颜组合物对部分测试者面部粉刺、丘疹、脓疱改善非常明显,并且显示出较好的洁净清颜效果,如图1所示。
最后说明的是,以上优选实施例仅用于说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。
Claims (4)
1.一种控油祛痘清颜组合物,其特征在于:包含以下重量百分含量的组分:30-90%库拉索芦荟叶水、0.0005-0.05%季铵盐-73、0.0005-0.05%六肽-5、0.0002-0.02%棕榈酰三肽-8、0.0002-0.02%六肽-11、0.00002-0.002%三氟乙酰三肽-2。
2.权利要求1所述的控油祛痘清颜组合物,其特征在于:包含以下重量百分含量的组分:40-80%库拉索芦荟叶水、0.001-0.008%季铵盐-73、0.002-0.008%六肽-5、0.001-0.003%棕榈酰三肽-8、0.001-0.003%六肽-11、0.0001-0.0003%三氟乙酰三肽-2。
3.权利要求1-2所述的控油祛痘清颜组合物,其特征在于:包含以下重量百分含量的组分:50-70%库拉索芦荟叶水、0.003-0.007%季铵盐-73、0.003-0.007%六肽-5、0.0015-0.0025%棕榈酰三肽-8、0.0014-0.0026%六肽-11、0.00017-0.00023%三氟乙酰三肽-2。
4.权利要求1-3所述的控油祛痘清颜组合物作为护肤品添加剂的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211627852.4A CN115737520A (zh) | 2022-12-16 | 2022-12-16 | 一种控油祛痘清颜组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211627852.4A CN115737520A (zh) | 2022-12-16 | 2022-12-16 | 一种控油祛痘清颜组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115737520A true CN115737520A (zh) | 2023-03-07 |
Family
ID=85346519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211627852.4A Pending CN115737520A (zh) | 2022-12-16 | 2022-12-16 | 一种控油祛痘清颜组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115737520A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038337A (zh) * | 2016-07-06 | 2016-10-26 | 大连苗谣青颜生物科技有限公司 | 祛痘美肤液及其制法 |
CN107375041A (zh) * | 2017-09-11 | 2017-11-24 | 苏州纳康生物科技有限公司 | 一种含多肽的护肤油凝胶 |
CN107412097A (zh) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | 一种祛痘修复精华液 |
CN109364006A (zh) * | 2018-12-03 | 2019-02-22 | 广州润虹医药科技股份有限公司 | 一种祛痘组合物、精华液及其制备方法 |
CN110960453A (zh) * | 2019-12-27 | 2020-04-07 | 杭州菲丝凯化妆品有限公司 | 一种抗衰修复精华液及其制备方法 |
CN113520896A (zh) * | 2021-08-01 | 2021-10-22 | 青海瑞肽生物科技有限公司 | 一种具有祛痘和修复痘印功能的组合物及制备方法 |
-
2022
- 2022-12-16 CN CN202211627852.4A patent/CN115737520A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038337A (zh) * | 2016-07-06 | 2016-10-26 | 大连苗谣青颜生物科技有限公司 | 祛痘美肤液及其制法 |
CN107412097A (zh) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | 一种祛痘修复精华液 |
CN107375041A (zh) * | 2017-09-11 | 2017-11-24 | 苏州纳康生物科技有限公司 | 一种含多肽的护肤油凝胶 |
CN109364006A (zh) * | 2018-12-03 | 2019-02-22 | 广州润虹医药科技股份有限公司 | 一种祛痘组合物、精华液及其制备方法 |
CN110960453A (zh) * | 2019-12-27 | 2020-04-07 | 杭州菲丝凯化妆品有限公司 | 一种抗衰修复精华液及其制备方法 |
CN113520896A (zh) * | 2021-08-01 | 2021-10-22 | 青海瑞肽生物科技有限公司 | 一种具有祛痘和修复痘印功能的组合物及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111407719B (zh) | 一种皮肤屏障修护复合物、面霜及其制备方法 | |
CN107854367B (zh) | 一种针对敏感肌肤修复的精华液 | |
CN110769836B (zh) | 预防和治疗痤疮和激素依赖性皮炎的生物多糖及其应用 | |
CN113750015B (zh) | 一种具有祛痘印、祛痘疤功效的祛痘组合物及制备方法 | |
KR100881884B1 (ko) | 복합 생약 추출물을 유효성분으로 함유하는 피부염 질환의예방 및 치료용 조성물 | |
CN112569152B (zh) | 一种控油抗炎的植物组合提取物及其制备方法和应用 | |
CN115025024B (zh) | 一种祛痘消印组合物及其应用 | |
CN112426390A (zh) | 一种天然中药祛痘组合物及其制备方法 | |
CN113842340A (zh) | 一种抑菌止痒褪红祛痘修复组合物及其应用 | |
CN109498523B (zh) | 一种防皲裂护肤品及其制备 | |
CN104707057B (zh) | 一种具有祛痘功效的组合物及其制备方法和应用 | |
CN112516066B (zh) | 一种控油组合物及其在化妆品中的应用 | |
CN115054566B (zh) | 一种抗头皮衰老组合物及其制备方法 | |
CN116617106A (zh) | 一种原人参三醇皂苷舒敏修护组合物及其制备方法和应用 | |
CN115025150B (zh) | 一种治疗炎症性皮肤病的中药组合物、洗剂 | |
CN115737520A (zh) | 一种控油祛痘清颜组合物 | |
KR102071586B1 (ko) | 민감성피부 및 피부트러블 개선용 시트마스크팩 조성물 | |
CN113143788A (zh) | 一种具有保湿修复舒缓的多效组合物及面霜 | |
CN112807238A (zh) | 一种皮肤抗炎舒缓修护凝胶及其制备方法 | |
WO2002085390A1 (en) | Composition and method for the prevention and treatment of acne | |
KR100553810B1 (ko) | 질경이 추출물을 함유하는 피부 외용제 조성물 | |
CN113768803B (zh) | 一种防脱发去屑喷剂的组合物及制备方法 | |
CN115671167B (zh) | 一种具有祛痘功效的中药组合物制备方法及用途 | |
CN102357145A (zh) | 一种治疗秃发的外用药软膏 | |
CN109674890B (zh) | 预防和/或治疗皮肤红血丝的组合物和护肤品及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |